Merck & Co. faces a number of disputes with its insurers over coverage for the huge potential liability it faces stemming from the Texas jury verdict in favor of the plaintiff in the first Vioxx product liability case.
According to the Whitehouse Station, N.J.-based company's 10-Q filed for the second quarter of this year, the company has product liability coverage for claims brought in the Vioxx product liability lawsuits with stated upper limits of about $630 million after deductibles and co-insurance.
Vioxx is a painkiller, known as a Cox-2 inhibitor, primarily used by people with arthritis.
Recommended For You
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
